Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Not all neonicotinoids are the same, study finds
Bee on a flower
Researchers tested 75 bee colonies at five separate locations in Scotland.
Both imidacloprid and thiamethoxam exhibit toxicity, but not clothiandin

New research conducted by the University of Dundee has revealed that not all neonicotinoids are the same.

There has been growing concern over the risk to bee populations from neonicotinoid insecticides and their long-term consequences to the ecosystem and food security.

But a new study shows that one neonicotinoid - clothianidin - does not show the same detrimental effects on bee colonies as its close chemical relatives imidacloprid and thiamethoxam. All three have been subjected to EU-wide bans on their use.

Study leader Dr Chris Connolly, reader in division of neurosciece at Dundee's School of Medicine, said: “Our knowledge of the risk of neonicotinoids to bees is based on studies of imidacloprid and thiamethoxam and these findings have generally been extrapolated to clothianidin.

“However, in this study we have looked at the three neonicotinoids in parallel. What we have found is that imidacloprid and thiamethoxam, but not clothiandin, exhibit toxicity to bumblebee colonies when exposed at field-relevant levels.

“There was also further variation in the effects on bees between the three insecticides. So we can clearly see that the banned neonicotinoids are not the same, so they should be considered independently when considering risk and legislation.

“From our findings, we consider that it is premature to place a permanent ban on the use of clothianidin. That said, a moratorium on its use should continue until the knowledge gaps are filled on its wider impact on other species.”

In the study researchers tested 75 bee colonies at five separate locations in Scotland.

Dr Connolly says that the study once again confirms the threat to bumblebees from imidacloprid and thiamethoxam.

“We have seen further evidence to indicate the risk from these insecticides, including deficits in colony strength,” he said.

“Given these findings, small changes in the pesticide structure or its target site in insects are likely to be critical to risk assessment and each pesticide/insect combination needs to be considered independently - evidence should not be extrapolated to similar chemicals or insects. Real risk must be determined empirically.”

The results of the study are published in the journal Scientific Reports.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.